Top Links

Articles Related to Schizophrenia

Relationship between Self-Stigma and Quality of Life among Patients with Schizophrenia

Individuals who are diagnosed with severe mental illness (SMI) such as schizophrenia have always been viewed publicly as being hazardous, violent, aggressive and unpredictable. Their awareness of the fact that they are being discriminated against and stereotyped results in an intense feeling of being devalued by the society, which is referred to as Self-stigma [1,2].
View complete article: PDF  |  Full-text

Relationship between Insight, Self-Stigma and Level of Hope among Patients with Schizophrenia

View complete article: PDF  |  Full-text

Prodromal Symptoms and Signs of First Episode Schizophrenia in Iraq

Onset of schizophrenia is often preceded by other symptoms and types of behaviour, usually referred to as prodromal symptoms. Identify the main prodromal symptoms and signs preceding the full blown picture of first episode schizophrenia. This is a cross-section study. 328 Iraqi first episode schizophrenic inpatients admitted to Ibn-Rushed psychiatric mental hospital were examined during the period June, 1st, 2009 to June, 1st, 2011. Diagnosis confirmed through a Structured Clinical Interview for DSM-IV-TR. List of sociodemographic and clinical data was used. Detailed psychiatric history taking and mental state examination were applied. Supplemental information was obtained from patients and family members.
View complete article: PDF  |  Full-text

Neuropsycological Function, Insight, and Treatment Adherence among Patients with Schizophrenia

Research has suggested that poor insight in patients with schizophrenia is associated with poorer treatment compliance. One factor ontributing to poor insight may be neurocognitive deficits. The aim of the current study is to explore the relationship between cognitive insight, clinical insight, treatment adherence, executive functions and sustained attention within patients with schizophrenia. The study was conducted on 41 patients with schizophrenia using the Beck cognitive insight scale, the schedule for assessment of insight, the drug attitude inventory and two neuropsychological tests.
View complete article: PDF  |  Full-text

Acquired Factor XII Deficiency in a Patient with Schizophrenia

We report a 50-year-old man who presented schizophrenia and an abnormal coagulation profile indicative of an inhibitor. Clinical experiments demonstrated prolonged partial thromboplastin time along with acquired factor XII deficiency and a positive anticoagulant antibody. To the best of our knowledge, the coexistence of schizophrenia and anticoagulant antibody with deficiency of coagulation factor XII is extremely rare that has not previously been reported. This patient has also indicated the paraplegia associated with spinal tuberculosis along with the loss of bladder and bowel control. Herein, we present the case of a chronic schizophrenia patient who developed the anticoagulant antibody and abnormally low serum levels of factor XII.
View complete article: PDF  |  Full-text

DNA Methylation Status of the Methylenetetrahydrofolate Reductase Gene is associated with Depressive Symptoms in Japanese Workers: A Cross-Sectional Study

Polymorphisms in methylenetetrahydrofolate reductase (MTHFR) gene, that is considered to be the most important genetic determinant of blood homocysteine concentration, are associated with various diseases, including psychiatric disorders. However, the epigenetic factors influencing on the transcription and expression of this gene are unclear.
View complete article: PDF  |  Full-text

Lead (Pb) Toxicity Trigger Schizophrenia in Battery Workers of North Region of India

Total production of Pb acid batteries in India is about 8 million per year and nearly 10,000 Kg of Pb is consumed in the production of batteries.
View complete article: PDF  |  Full-text

Orally Disintegrating Tablets: A Short Review

This article summarizes the advantages of orally disintegrating tablets (ODTs) as well as critical issues during evaluation of ODTs such as bioequivalence and challenges and limitations of ODTs and finally present and the future of ODTs. ODTs have received everincreasing demand and the field has become a rapidly growing area in the pharmaceutical industry.
View complete article: PDF  |  Full-text

Methadone and Torsade De Pointes in the Therapeutic Range

Methadone, a long-acting opioid agonist, binds to and occupies mu-opioid receptors, preventing withdrawal symptoms for 24 hours or longer, reduces craving for opioids, and, by maintaining high levels of opioid tolerance, reduces the euphoric effects of subsequent illicit opioid use. As a controlled substance with potential for abuse, methadone use is regulated in the US and other countries.
View complete article: PDF  |  Full-text

Hydrocephalus in Congenital Rubella Syndrome: A Case Report

The Congenital Rubella Syndrome is a multisystemic disease and CNS involvement occurs in the form of microcephaly, mental/motor disabilities, leptomeningitis, encephalitis, vascular damage and retardation of myelination. We report a case of gross non-communicating hydrocephalus in a neonate of Congenital Rubella Syndrome which is a rare presentation.
View complete article: PDF  |  Full-text


Editorial Board Members Related to Schizophrenia

Wayne Brake

Professor
Department of Psychology
Center for Studies in Behavioral Neurobiology
Concordia University
Canada

XU-FENG HUANG

Professor
School of Health Sciences
University of Wollongong
Australia

Shiva Singh

Professor
University of Western Ontario
Canada

Hsien-Yuan Lane

Professor
Director and Professor
Department of Psychiatry
China Medical University Hospital.

Marco Weiergraber

Principal Investigator & Group leader
Neuropsychopharmacology
Federal Institute for Drugs and Medical Devices
Germany
Submit Manuscript


Open Access Journals

View All Journals